Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.
Eur J Cancer Care (Engl)
; 28(6): e13164, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571304
3.
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
Ther Adv Med Oncol
; 16: 17588359241248336, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686016
4.
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1.
J Clin Oncol
; 39(18): 2005-2015, 2021 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780274
5.
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Ther Adv Med Oncol
; 13: 17588359211053416, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777582